Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar

Introduction: Multidrug resistant tuberculosis (MDR-TB) is caused by Infection with Mycobacterium tuberculosis which is resistant to both isoniazid (INH) and rifampicin (RIF), with or without any other anti tubercular drug. It is caused by resistant mutant strains due to inadequate treatment an...

Full description

Bibliographic Details
Main Authors: Sunita Tripathy, Rajesh Kumar, Surya Deo Singh
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-11-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/6793/14024_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(P)_PF2(PAG).pdf
_version_ 1818834162131402752
author Sunita Tripathy
Rajesh Kumar
Surya Deo Singh
author_facet Sunita Tripathy
Rajesh Kumar
Surya Deo Singh
author_sort Sunita Tripathy
collection DOAJ
description Introduction: Multidrug resistant tuberculosis (MDR-TB) is caused by Infection with Mycobacterium tuberculosis which is resistant to both isoniazid (INH) and rifampicin (RIF), with or without any other anti tubercular drug. It is caused by resistant mutant strains due to inadequate treatment and poor compliance. Due to time taking conventional diagnostic methods, drug resistant strains continue to spread. Therefore rapid diagnosis and treatment of MDR-TB strains are prerequisites for the worldwide fight against TB. Objective: To determine the prevalence of MDR TB in North Bihar by molecular diagnostic method and to facilitate early diagnosis and treatment. Also, to find out the number of those diagnosed cases who were successfully initiated the treatment in MDR TB Centre of DMCH. Materials and Methods: This six month observational study was carried out in IRL Darbhanga, Damien TB research Centre of the Darbhanga Medical College and Hospital, Bihar, India. During the period of February-July 2014, 256 sputum samples were collected from suspected cases of multidrug resistant tuberculosis, from 6 districts of North Bihar around Darbhanga. These samples were subjected to routine microscopy and culture to detect Mycobacterium tuberculosis. Positive cases were subjected to drug sensitivity test by a molecular diagnostic method, Using Genotype MTBDR plus kit. Result: Out of 256 sputum samples from suspected cases of MDR TB, 122 cases were microscopy positive for tuberculosis. Among these 122 cases, tuberculosis was confirmed by PCR in 114 cases. Finally with the help of Line Probe Assay (LPA), 39(15%) samples were found to have resistance to both INH and Rifampicin. Male female ratio was 4:1. Conclusion: The Prevalence of Multi drug resistant pulmonary tuberculosis in North Bihar is 15%. It needs early diagnosis by molecular diagnostic method and prompt treatment to reduce the spread of MDR TB cases.
first_indexed 2024-12-19T02:30:26Z
format Article
id doaj.art-7c061cb6e216442b88e798dac978750b
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-19T02:30:26Z
publishDate 2015-11-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-7c061cb6e216442b88e798dac978750b2022-12-21T20:39:40ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-11-01911LC09LC1210.7860/JCDR/2015/14024.6793Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North BiharSunita Tripathy0Rajesh Kumar1Surya Deo Singh2Professor, Department of Biochemistry, Darbhanga Medical College, Darbhanga, India.Senior, Medical Officer, DRTB Centre, DMCH, Darbhanga, India.Associate Professor, Department of Preventive and Social Medicine, DMCH, Darbhanga, India.Introduction: Multidrug resistant tuberculosis (MDR-TB) is caused by Infection with Mycobacterium tuberculosis which is resistant to both isoniazid (INH) and rifampicin (RIF), with or without any other anti tubercular drug. It is caused by resistant mutant strains due to inadequate treatment and poor compliance. Due to time taking conventional diagnostic methods, drug resistant strains continue to spread. Therefore rapid diagnosis and treatment of MDR-TB strains are prerequisites for the worldwide fight against TB. Objective: To determine the prevalence of MDR TB in North Bihar by molecular diagnostic method and to facilitate early diagnosis and treatment. Also, to find out the number of those diagnosed cases who were successfully initiated the treatment in MDR TB Centre of DMCH. Materials and Methods: This six month observational study was carried out in IRL Darbhanga, Damien TB research Centre of the Darbhanga Medical College and Hospital, Bihar, India. During the period of February-July 2014, 256 sputum samples were collected from suspected cases of multidrug resistant tuberculosis, from 6 districts of North Bihar around Darbhanga. These samples were subjected to routine microscopy and culture to detect Mycobacterium tuberculosis. Positive cases were subjected to drug sensitivity test by a molecular diagnostic method, Using Genotype MTBDR plus kit. Result: Out of 256 sputum samples from suspected cases of MDR TB, 122 cases were microscopy positive for tuberculosis. Among these 122 cases, tuberculosis was confirmed by PCR in 114 cases. Finally with the help of Line Probe Assay (LPA), 39(15%) samples were found to have resistance to both INH and Rifampicin. Male female ratio was 4:1. Conclusion: The Prevalence of Multi drug resistant pulmonary tuberculosis in North Bihar is 15%. It needs early diagnosis by molecular diagnostic method and prompt treatment to reduce the spread of MDR TB cases.https://jcdr.net/articles/PDF/6793/14024_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(P)_PF2(PAG).pdfdr tb (drug resistant tuberculosis)inh (isoniazide)irl (intermediate referral laboratory)lpa (line probe assay)programmatic management of drug resistant tb (pmdt)
spellingShingle Sunita Tripathy
Rajesh Kumar
Surya Deo Singh
Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
Journal of Clinical and Diagnostic Research
dr tb (drug resistant tuberculosis)
inh (isoniazide)
irl (intermediate referral laboratory)
lpa (line probe assay)
programmatic management of drug resistant tb (pmdt)
title Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
title_full Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
title_fullStr Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
title_full_unstemmed Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
title_short Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar
title_sort prevalence of multidrug resistant pulmonary tuberculosis in north bihar
topic dr tb (drug resistant tuberculosis)
inh (isoniazide)
irl (intermediate referral laboratory)
lpa (line probe assay)
programmatic management of drug resistant tb (pmdt)
url https://jcdr.net/articles/PDF/6793/14024_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(P)_PF2(PAG).pdf
work_keys_str_mv AT sunitatripathy prevalenceofmultidrugresistantpulmonarytuberculosisinnorthbihar
AT rajeshkumar prevalenceofmultidrugresistantpulmonarytuberculosisinnorthbihar
AT suryadeosingh prevalenceofmultidrugresistantpulmonarytuberculosisinnorthbihar